The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

AdChoices
 

Zoetis Inc

NYSE: ZTS
Last

(U.S.) $39.36

Today's change+0.03 +0.08%
Updated February 11 4:06 PM EST. Delayed by at least 15 minutes.
 

Zoetis Inc

NYSE: ZTS
Last

(U.S.) $39.36

Today's change+0.03 +0.08%
Updated February 11 4:06 PM EST. Delayed by at least 15 minutes.

Zoetis Inc up slightly

Zoetis Inc closed up just (U.S.)$0.03 Thursday to (U.S.)$39.36. Over the last five days, shares have lost 5.25% and sit 4.32% above their 52-week low. This security has underperformed the S&P 500 by 2.43% during the last year.

Key company metrics

  • Open(U.S.) $38.98
  • Previous close(U.S.) $39.33
  • High(U.S.) $39.53
  • Low(U.S.) $38.26
  • Bid / Ask-- / --
  • YTD % change-17.86%
  • Volume8,058,209
  • Average volume (10-day)5,386,635
  • Average volume (1-month)4,383,217
  • Average volume (3-month)3,832,874
  • 52-week range(U.S.) $37.73 to (U.S.) $55.38
  • Beta--
  • Trailing P/E44.67×
  • P/E 1 year forward22.72×
  • Forward PEG1.62×
  • Indicated annual dividend(U.S.) $0.38
  • Dividend yield0.97%
  • Trailing EPS(U.S.) $0.88
Updated February 11 4:06 PM EST. Delayed by at least 15 minutes.

Profit

Net Profit (TTM)
+9.25%

Based on its net profit margin of 9.25%, Zoetis Inc is among the more effective companies in its industry at turning revenues into bottom line profit.
Company Books

S&P TSX0.81%Sector:HealthcareIndustry:Pharmaceuticals - Generic & Specialty

Latest Company News

View more News
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q3/2015Q2/2015Q1/2015Q4/2014
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedSep 27, 201509/27/2015Jun 28, 201506/28/2015Mar 29, 201503/29/2015Dec 31, 201412/31/2014
Revenue1,2141,1751,1021,320
Total other revenue--------
Total revenue1,2141,1751,1021,320
Gross profit793748708829
Total cost of revenue421427394491
Total operating expense9411,2028721,165
Selling / general / administrative374379354497
Research & development918480124
Depreciation / amortization15151514
Interest expense (income), net operating29292830
Unusual expense (income)13268113
Other operating expenses, total-8-4-8-9
Operating income273-27230155
Interest income (expense), net non-operating--------
Gain (loss) on sale of assets--------
Other--------
Income before tax273-27230155
Income after tax190-36165126
Income tax, total8396529
Net income189-37165126
Total adjustments to net income--------
Net income before extra. items189-37165126
Minority interest-1-100
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items189-37165126
Inc. avail. to common incl. extra. items189-37165126
Diluted net income189-37165126
Dilution adjustment----0--
Diluted weighted average shares502500503503
Diluted EPS excluding extraordinary itemsvalue per share0.38-0.070.330.25
Dividends per sharevalue per share0.080.000.080.16
Diluted normalized EPSvalue per share0.390.270.330.27